These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14767648)

  • 21. Dorzolamide-timolol combination and retinal vessel oxygen saturation in patients with glaucoma or ocular hypertension.
    Traustason S; Hardarson SH; Gottfredsdottir MS; Eysteinsson T; Karlsson RA; Stefánsson E; Harris A
    Br J Ophthalmol; 2009 Aug; 93(8):1064-7. PubMed ID: 19416932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery.
    Ozkurt Y; Oral Y; Karacan O; Comez A; Dogan OK
    Eye Contact Lens; 2008 Jan; 34(1):21-3. PubMed ID: 18180678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma.
    Rismanchian A; Eslami F; Moeini H; Attarzade H; Naderibeni A
    Saudi Med J; 2008 Mar; 29(3):384-7. PubMed ID: 18327364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
    Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
    Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination: randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens.
    Wirtitsch MG; Menapace R; Georgopoulos M; Rainer G; Buehl W; Heinzl H
    J Cataract Refract Surg; 2007 Oct; 33(10):1754-9. PubMed ID: 17889772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of topical antiglaucoma application on conjunctival impression cytology specimens.
    Hong S; Lee CS; Seo KY; Seong GJ; Hong YJ
    Am J Ophthalmol; 2006 Jul; 142(1):185-6. PubMed ID: 16815281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes.
    Dietrich UM; Chandler MJ; Cooper T; Vidyashankar A; Chen G
    Vet Ophthalmol; 2007; 10 Suppl 1():95-100. PubMed ID: 17973840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interaction of antiglaucomatous drugs and melanin granule].
    Nagata A
    Nippon Ganka Gakkai Zasshi; 1991 Jul; 95(7):644-9. PubMed ID: 1927743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension.
    Suzuki ER; Franklin LM; da Silva LJ; Figueiredo CR; Netto JA; Batista WD
    Curr Med Res Opin; 2006 Sep; 22(9):1799-805. PubMed ID: 16968583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of antiglaucomatous drugs to synthetic melanin and their hypotensive effects on pigmented and nonpigmented rabbit eyes.
    Nagata A; Mishima HK; Kiuchi Y; Hirota A; Kurokawa T; Ishibashi S
    Jpn J Ophthalmol; 1993; 37(1):32-8. PubMed ID: 8100592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C; Tanaka M
    J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
    Konstas AG; Kozobolis VP; Tsironi S; Makridaki I; Efremova R; Stewart WC
    Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
    Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy.
    Sonty S; Henry JC; Sharpe ED; Weiss MJ; Stewart JA; Nelson LA; Stewart WC
    Acta Ophthalmol; 2008 Jun; 86(4):419-23. PubMed ID: 18039347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol.
    Costagliola C; Campa C; Parmeggiani F; Incorvaia C; Perri P; D'Angelo S; Lamberti G; Sebastiani A
    Br J Clin Pharmacol; 2007 Mar; 63(3):376-9. PubMed ID: 16981897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
    Hasegawa T; Hara K; Hata S
    Drug Metab Dispos; 1994; 22(3):377-82. PubMed ID: 8070313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.